from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1632c/-

LFCtreatmentdescriptionclass of inhibitor

-0.078

Amikacinug/mL Amikacintranslation

-0.174

Cap5-10ug/mL Capreomycintranslation

0.201

Rox10-50 ug/mL Roxithromycintranslation

0.275

SM2-5 ug/mL Streptomycintranslation

0.846

Tet5-10 ug/mL Tetracyclinetranslation

-0.999

Rif0.2-5ug/mL Rifampicintranscription

0.201

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.720

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.060

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.010

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.129

Clofazimine10-13 ug/mL Clofaziminerespiration

0.130

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.658

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.267

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.204

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.016

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.129

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.506

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.598

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.218

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.142

KCN5-20 ug/mL Potassium cyaniderespiration

-0.179

NaN30.2-2 mM Sodium aziderespiration

-0.106

Nigericin50 uM Nigericinrespiration

-0.966

TRC10-150 ug/mL Triclosanrespiration

-0.855

TRZ10-25 ug/mL Thioridazinerespiration

-0.341

Valinomycin0.5-10 uM Valinomycinrespiration

0.599

ZnSO42 mM ZnSO4respiration

-0.930

menadione6-10 ug/mL Menadionerespiration

-0.160

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.821

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.407

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.906

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.067

NRP_1Non-replicating persistence stage 1dosRassociated

1.355

Amp0.2mg/mL AmpicillincellWall

0.931

Cephalexin20-100 ug/mL CephalexincellWall

-0.282

Cerulenin0.32-5 ug/mL CerulenincellWall

0.244

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.289

EMB10-20 ug/mL EthambutolcellWall

0.218

Eta12-40 ug/mL EthionamidecellWall

-0.039

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.391

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.927

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.145

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.877

BZA0.12 mg/mL BenzamidearomaticAmides

0.733

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.196

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.594

H2O24 mM hydrogen peroxideDNAdamaging

-0.110

Levo10 ug/mL LevofloxacinDNAdamaging

0.350

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.526

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.944

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.494

UVUV-irradiationDNAdamaging

-1.833

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.222

Antimycin12.5-50 ug/mL Antimycin A?

0.913

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.051

PA_110-50 ug/mL Antitubercular compound PA-1?

0.375

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.293

PA8240.2-2 ug/mL PA-824?

-0.533

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.593

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.845

Verapamil50 uM Verapamil?

-0.018

mercaptoethanol2 mM 2-Mercaptoethanol?

1.180

methoxatin10-20 ug/mL Methoxatin?